Children's Hospital is part of the UPMC family.
This Pediatric Brain Tumor Research Consortium trial is studying how well peginterferon alfa-2b (PEGIntron) works in treating younger patients with a craniopharyngioma that is recurrent or cannot be removed by surgery. PEGIntron may interfere with the growth of tumor cells and slow the growth of craniopharyngioma.
Subject to certain exclusion criteria, this study is open to males and females, ages 18 months to 25 years old, who have craniopharyngioma that is recurrent or cannot be surgically removed.
Males and Females: Ages 18 months to 25 years
Following an initial physical exam, participants will receive PEGIntron via injection at home once a week for each week of a 6-week course. This will be repeated for up to 18 courses. At specific intervals, researchers will require other tests, including blood and urine tests, ophthalmology evaluations and MRI scans of the brain.
Duration: Approximately 2 years
Pediatric Brain Tumor Consortium (Study PBTC-039)
National Cancer Institute
Study Description at National Institutes of Health
A. Kim Ritchey, MD
For more information about the study or enrollment, please contact:
Research Coordinator Angela Connelly, RN, BSN
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Visit Children's Hospital of Pittsburgh Foundation's website to make a donation online.